Contact Information
Summary
Colin Regenauer earned dual B.A.s in Biology and Neuroscience from the University of Chicago, graduating magna cum laude. He is currently a postbaccalaureate fellow in the Molecular Immunology and Inflammation branch, where he studies chromatin organization in Type II immune cells. As a member of the Molecular Immunology and Inflammation branch, Colin is excited to deepen his expertise in medicine and research, and he intends to pursue a medical degree in the future.
During his time at the University of Chicago, Colin was a member of the Reder Lab in the Department of Neurology at the University of Chicago Medicine. In this role, he investigated gene expression in peripheral blood mononuclear cells from multiple sclerosis patients, with a focus on how interferon-beta treatment affects antiviral gene induction and viral gene expression. Additionally, he explored the role of CD8+ regulatory T cells in MS patients on Fingolimod therapy. As an undergraduate, Colin was also an active participant in the Katen Scholars Program, a program dedicated to addressing social challenges within medicine, and was a lab mentor for both the Biological Sciences and Neuroscience Divisions.
Research Statement
Colin's research focuses on Type 2 cytokine responses and their pathological implications for allergy, asthma, and oral tolerance. He is particularly interested in how genome architecture at the Il9 locus may provide insights into T helper and innate lymphoid cells' context-dependent and cell-type-specific functions.
Education
University of Chicago
B.A. in Biological Sciences (2019-2024)
University of Chicago
B.A. in Neuroscience (2019-2024)
Experience
Research Assistant
Reder Lab, Department of Neurology, University of Chicago Medicine (2020-2024)